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Abstract
Background: Head trauma is one of the most important clinical issues that not only can be fatal and disabling,
requiring long-term treatment and care, but also can cause heavy financial burden. Formation or distribution of
free oxygen radicals should be decreased to enable fixing of poor neurological outcomes and to prevent neuronal
damage secondary to ischemia after trauma. Coenzyme Q10 (CoQ10), a component of the mitochondrial electron
transport chain, is a strong antioxidant that plays a role in membrane stabilization. In this study, the role of CoQ10
in the treatment of head trauma is researched by analyzing the histopathological and biochemical effects of CoQ10
administered after experimental traumatic brain injury in rats. A traumatic brain-injury model was created in all rats.
Trauma was inflicted on rats by the free fall of an object of 450 g weight from a height of 70 cm on the
frontoparietal midline onto a metal disc fixed between the coronal and the lambdoid sutures after a midline
incision was carried out.
Results: In the biochemical tests, tissue malondialdehyde (MDA) levels were significantly higher in the traumatic
brain-injury group compared to the sham group (p < 0.05). Administration of CoQ10 after trauma was shown to be
protective because it significantly lowered the increased MDA levels (p < 0.05). Comparing the superoxide
dismutase (SOD) levels of the four groups, trauma + CoQ10 group had SOD levels ranging between those of sham
group and traumatic brain-injury group, and no statistically significant increase was detected. Histopathological
results showed a statistically significant difference between the CoQ10 and the other trauma-subjected groups with
reference to vascular congestion, neuronal loss, nuclear pyknosis, nuclear hyperchromasia, cytoplasmic eosinophilia,
and axonal edema (p < 0.05).
Conclusion: Neuronal degenerative findings and the secondary brain damage and ischemia caused by oxidative
stress are decreased by CoQ10 use in rats with traumatic brain injury.
1 Background
Head trauma is one of the most important clinical issues
that not only can be fatal and disabling, requiring long-
term treatment and care, but also can cause heavy
financial burden. It ranks fourth among all the causes of
death [1]. Brain injury secon d a r yt ot r a u m ac o n s i s t so f
the primary damage formed by the direct effect of forces
faced and the subsequent secondary damage formed by
the sequential reactions of various metabolic events
[2-7].
A huge part of the secondary brain damage is induced
by lipid peroxidation caused by free oxygen radicals
released due to impairment of the balance between the
various antioxidant mechanisms occurring after brain
trauma.
The formation or distribution of free oxygen radicals
should be decreased to enable the fixing of poor neuro-
logical outcomes and to prevent neuronal damage sec-
ondary to ischemia after trauma [2-8]. It is assumed that
the antioxidant defense system cannot completely neu-
tralize the free oxygen radicals occurring in ischemic
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any medium, provided the original work is properly cited.tissues, particularly after reperfusion [6]. Agents inhibit-
ing free oxygen radicals have also been reported to
improve poor neurological outcomes in the central ner-
vous system after trauma or ischemia by their therapeu-
tic effects [2-9].
Coenzyme Q10 (CoQ10), a component of the mito-
chondrial electron transport chain, is a strong antioxi-
dant playing a role in membrane stabilization [10].
Experimental studies have found that CoQ10 is effective
in the treatment of ischemia-reperfusion injury [11,12].
Various studies have also shown that CoQ10 inhibits
lipid peroxidation and is as effective as alpha-tocopherol
against free oxygen radicals; moreover, tissue levels of
CoQ9 and CoQ10decrease after transient cerebral ische-
mia [11-13]. CoQ10 has also been reported to decrease
brain lactate levels and lessen the diameter of ischemic
lesions in animal models [14-16].
I nt h i ss t u d y ,t h er o l eo fC o Q 10 in the treatment of
head trauma was researched by analyzing the histo-
pathological and biochemical effects of CoQ10 adminis-
tered to rats after experimental traumatic brain injury.
2 Methods
2.1 Animals
The study was approved by the Ethics Committee of the
School of Medicine, University of Karaelmas. A total of
28 Wistar albino adult male rats, weighing 350-400 g on
average, were used in this study. This animal study was
conducted in the Central Experimental and Clinical
Research Laboratory, Faculty of Medicine, University of
Karaelmas. All the rats were placed in a room main-
tained at 22-25°C, with appropriate humidity and a 12-
hour light cycle, and were provided with sufficient fluids
and feed.
2.2 Traumatic Brain Injury
A moderate brain-injury model, described by Marmarou
et al. [17] and modified by Uçar et al. [18], was applied
for head trauma to become a closed one and lead to
reproducible brain injury. Anesthesia under spontaneous
respiration was enabled with intraperitoneal administra-
tion of 50 mg/kg body weight ketamine hydrochloride
(Ketalar, 50 mg/ml, 10 ml vial, Pfizer İlaçları Ltd., Istan-
bul) and 10 mg/kg body weight xylazine hydrochloride
(Rompun, 2% solution, 50 cc vial, Bayer-Türk İlaç Ltd.,
Istanbul). The rats were placed in a prone position on
the table. A midline incision was made on the head, and
the coronal and lambdoid sutures were placed. A metal-
lic disc of 10-mm diameter and 3-mm thickness was
fixed to the cranium using bone wax between the two
sutures and in the midline. Trauma was applied at the
point where the metal disc was placed in the midline. A
lead object weighing 450 g was allowed to fall freely
from a height of 70 cm through a copper tube onto the
metal disc over the skulls of the rats.
2.3 Experimental Groups
The rats were divided into four equal groups. For rats in
the sham group, a scalp incision was made (G1). A trau-
matic brain injury was induced in the rats of the G2,
G3, and G4 groups. Rats in the G3 group were adminis-
tered 2 ml of 0.9% NaCl (physiologic saline) immediately
after trauma and at the 24th hour by gavage. The rats in
the G4 group were administered CoQ10 a tad o s eo f1 0
mg/kg immediately after trauma and at the 24th hour
by gavage.
All the rats were anesthetized with the above-men-
tioned agents at the 48th hour after trauma, and their
brains were extracted immediately without any damage.
Samples of neural tissue were obtained by excising the
left frontoparietal lobes from the boundary of the inter-
hemispheric fissure and were subjected to biochemical
analyses. The remaining parts of the brains were main-




Tissue malondialdehyde (MDA) was measured by high-
performance liquid chromatography using Immundiag-
nostik (Bansheim, Germany) kits on a 10% homogenate
of the tissue in 50-mmol Tris-HCl buffer (pH 7.4). Sam-
ple separation was conducted with an analytical column
(Phenomenex, USA). The mobile phase was injected
into the system at a velocity of 1.0 ml/min with the help
of an isocratic pump. Measurements were conducted
using a fluorescence detector fitted in a Zivak Technolo-
gies apparatus under wavelengths of excitation and
emission of 515 and 553 nm, respectively. The MDA
concentrations were evaluated as nmol/g tissue divided
by the tissue weight in grams.
Tissue superoxide dismutase activity measurement
Superoxide dismutase (SOD) was measured by the
method of Sun et al. [19] using 10% tissue homogenate
in Tris buffer. The method is based on the principle
that the reduction of nitroblue tetrazolium (NBT) is
inhibited by the xanthine-xanthine oxidase system,
which acts as a superoxide generator. Inhibition percen-
tage was calculated using the following formula:
Percentage of inhibition = (Ablind − Asample)/(Ablind) × 100.
Sample absorbances were measured in a Shimadzu
UV-1601 spectrophotometer at 560 nm. One unit of
SOD was defined as the amount of enzyme causing 50%
inhibition in the rate of NBT reduction. SOD activity
was expressed as units per milligram protein.
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Serum paraoxonase (PON) activities were measured as
per the method of Eckerson et al. [20]. This method is
based on the measurement of the rate of hydrolysis of
paraoxon by the PON enzyme to form p-nitrophenol.
Serum PON enzyme activity, in units of IU/L, was cal-
culated by measuring the absorbance changes at 412 nm
caused by the p-nitrophenol formed between the zero
and the fifth minutes; the molar extinction coefficient of
p-nitrophenol, 16.900 mol
-1 cm
-1, was used for the cal-
culations [20].
2.5 Histopathological Procedures
The brain parenchymal tissues of all rats in all the
groups were embedded in paraffin and fixed with 10%
buffered formalin for 24 hours. Using a microtome, 5-
μm-thick serial sections were taken from the paraffin
blocks and stained with hematoxylin and eosin (H&E)
for routine histopathological observations. Sections of all
tissue samples were observed under a light microscope
(Leica, DMLS) in the Department of Pathology, Faculty
of Medicine, Zonguldak Karaelmas University.
A semiquantitative scoring system, ranging between
zero and three, was used for grading both the histo-
pathological changes (vascular congestion, intraparench-
ymal hemorrhage, inflammation, neuronal loss, and
gliosis) and the neuronal degenerative signs (nuclear
pyknosis, nuclear hyperchromasia, cytoplasmic eosino-
philia, and axonal edema) in the brain tissues of all his-
tological samples. Nine different parameters assessed
histopathologically were scored as follows: 0: absent; 1:
mild; 2: moderate; and 3: dense/common.
2.6 Statistical Analysis
Data were evaluated in computerized media using the
software SPSS 11.5. Results are presented as frequency,
median, minimum, and maximum values. Kruskal-Wallis
variance analysis was used for comparison of the bio-
chemical values among groups. In case any difference
was found, double-group comparisons were carried out
according to Conover. Likelihood ratio and Fisher exact
chi-square test were conducted for comparing the
results of the histopathological assessment; p values less
than 0.05 were considered significant.
3 Results
3.1 Biochemical findings
The biochemical results of the groups are presented in
Table 1. The MDA levels were increased, with statistical
significance (p < 0.05) in the G2 group compared with
G1. In G4, to which CoQ10 was administered immedi-
ately after trauma, a statistically significant decrease (p <
0.05) in the MDA levels was noticed when compared to
G2; moreover, this level was less than that in G1. The
MDA level was additionally found to be higher in G3
than in G2, without any statistical significance. SOD
levels were significantly lower in G2 and G3 than in G1
(p < 0.05). Comparing the SOD levels of the four groups
G4 to G1, G4 had SOD levels ranging between those of
G1 and G2, and no statistically significant increase was
detected. In terms of the levels of the PON enzyme, no
statistical difference was found between G2, G3, and G4
compared with G1.
3.2 Histopathological Findings
The parenchymal features of the white and grey matter,
the neuronal morphology, and the vascular structures
were assessed to be normal in the G1 samples. In the his-
topathological samples of G2 and G3, marked edema in
the white and grey matter, in addition to vascular conges-
tion were observed in the trauma-applied brain parench-
yma tissue, along with neuronal injury findings, including
hyperchromasia in neuronal nuclei, nuclear pyknosis,
cytoplasmic eosinophilic degeneration, and axonal
edema. Focal neuronal loss and gliotic zones were seen in
areas consistent with the trauma site. Histopathological
findings of the G2 and G3 groups were different from
those of G1, with statistical significance in terms of par-
enchymal congestion, neuronal loss, gliosis, nuclear
pyknosis, nuclear hyperchromasia, cytoplasmic eosino-
philia, and axonal edema (p < 0.05). Again, no significant
difference was observed between the sham group (G1)
and the other three groups (G2, G3, and G4) with refer-
ence to intraparenchymal hemorrhage and inflammation.
Table 1 MDA, SOD and paraoxonase alterations among groups (median, minimum-maximum)
G1 G2 G3 G4
Median min-max median min-max median min-max median min-max
MDA 6.20 (4.54-8.71) 7.66 (6.34-10.12) * 8.40 (6.40-12.13) ‡ 6.04 (4.79-6.96) #
SOD 6.15 (4.49-6.98) 4.44 (3.44-6.15) * 5.25 (4.26-5.41) ‡ 5.11 (4.61-6.29)
PARAOXONASE 37.14 (19.10-51.10) 45.42 (17.74-53.47) 21.05 (18.92-82.80) 27.44 (15.14-64.35)
*p > 0.05 (when compared to sham group).
#P < 0.05 (when compared to trauma group).
‡P < 0.05 (when compared to sham group).
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to those of G2 and G3, a statistically significant differ-
ence was detected in terms of vascular congestion, neu-
ronal loss, nuclear pyknosis, nuclear hyperchromasia,
cytoplasmic eosinophilia, and axonal edema (p < 0.05).
Moreover, the intensity of the signs of neuronal degen-
e r a t i o ni nG 4w a so b v i o u s l yl e s st h a nt h o s ei nG 2a n d
G3. However, no statistically significant difference was
observed among the three groups (G2, G3, and G4) in
terms of gliosis, intraparenchymal hemorrhage, and
inflammation (Table 2 and Figure 1).
4. Discussion
Head trauma may lead to primary and secondary
damages in neural tissue. Secondary factors that have
been shown to develop subsequent to traumatic brain
injury are ischemia, cerebral edema, and free oxygen
radical-based lipid peroxidation [2-7]. Lipid peroxidation
leads to dysfunction of membrane because of changes in
the lipid structure of the membrane. Secondary cell
injury is observed subsequent to inflammation, edema,
chemotaxis, and increased vascular permeability with
the development of free oxygen radicals, influencing
other components of the cell [21-23].
Antioxidants inhibit lipid peroxidation by preventing
the peroxidative chain reaction and/or picking up the
reactive-oxygen derivatives. Endogenous antioxidants
include mitochondrial cytochrome oxidase, SOD, cata-
lase, glutathione peroxidase, glutathione-S-transferase,
hydroperoxidase, and CoQ. CoQ10 is the only fat-soluble
antioxidant synthesized endogenously, and it is present
in tissues in the active form (reduced) independently
from the diet [24].
The method described by Marmarou et al. [17] and
modified by Uçar et al. [18] was used as the trauma
model in our study. We designed the model to analyze
the protective effect of CoQ10 on neuronal damage. In
the method of Marmarou et al. [17], the area between
the coronal and lambdoid sutures was targeted; a diffuse
brain injury was caused by allowing an object of 450 g
to fall freely from an altitude of two meters through a
plexiglass tube. A possible fracture of the calvarium was
prevented by a stainless steel plate stuck over the calvar-
ium, similar to the method of our application. In the
s t u d yo fM a r m a r o ue ta l . ,o ft h e5 4r a t s ,m o r t a l i t ya n d
cranium fracture were found in 44% and 12.5%, respec-
tively. We applied the moderate head-trauma model
described by Uçar et al. [18] because Marmarou et al.’s
model has both high mortality and risk of posttraumatic
seizure. Accordingly, we arranged for an object of 450 g
to fall through a plexiglass tube from an altitude of 70
cm onto target points around the coronal suture. The
total scheduled number of rats in the trauma groups
was 21 in our study. Among these, four rats died of
Table 2 Parenchymal features and neuronal morphology
distributions among groups
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to trauma and included into the study. Hence, a total of
25 rats were subjected to trauma and four (16%) died,
while no cranium fracture was detected in any rat.
CoQ10, whose use in many neurological, cardiac,
oncological, and immunological diseases has been stu-
died, has been shown to be protective against different
forms of tissue damage [25-28]. However, the efficacy of
CoQ10 in a moderate head-trauma model has not been
analyzed before.
Administration of a 10 mg/kg dose immediately after
t h et r a u m a ,w h i c hw ea p p l i e d, has been reported to
have a protective effect against ischemic injury in
experimental models, such as cerebral ischemia, tissue
ischemia-reperfusion damage, and spinal cord trauma
[12,26,29-32]. Li et al. [33], in a different study, showed
that the administration of CoQ10 three hours after focal
and global ischemia, which they formed by vessel occlu-
sion in rats, does not have a protective effect against
neural injury [33].
Ostrowski [12] induced cerebral ischemia by adminis-
trating intraventricular endothelin to rats in his study.
He showed that SOD activity increased significantly in
samples obtained by killing the subjects after he injected
10 mg/kg CoQ10 intraperitoneally at the end of the 24th
hour. His interpretation of this result was that CoQ10
would decrease cerebral ischemic injury if the endogen-
ous SOD activity was higher [12].
Erol et al. [29] found in their ischemia-reperfusion
model that MDA levels were significantly lower in the
group in which they applied a single dose of 10 mg/kg
CoQ10 intraperitoneally than that in control group.
They concluded that this could be attributable to
CoQ10, which had an antioxidant effect by lowering
lipid peroxidation.
Kerimoğlu et al. [32] analyzed the efficacy of CoQ10
on experimental spinal cord injury induced by placing
extradural aneurysm clips at the T4-5 level in rats, and
they found that the SOD activity of only the trauma-
applied group was significantly lower than that of the
control group (p < 0.05). Although the MDA levels were
less than those in the control group, the result was not
considered statistically significant. Again, although
edema was significantly more frequent in the control
groups compared to others during histopathological
assessment, no statistical difference was observed in
their study between the methylprednisolone, CoQ10, and
methylprednisolone + CoQ10 groups in terms of edema
and hemorrhage.
Herein, we measured (1) the levels of MDA, one of
the products of lipid peroxidation, for evaluating oxi-
dative stress, and (2) the activities of SOD and PON,
for analyzing the antioxidant capacity. A statistically
significant reduction (p < 0.05) in the MDA levels was
seen in the group administered CoQ10 immediately
a f t e rt r a u m a( G 4 )c o m p a r e dt ot h eg r o u pt ow h i c h
only trauma was applied (G2), and even lower results
than that in the sham group (G1) were detected.
When evaluating the results of SOD, an endogenous
antioxidant enzyme functioning as a member of the
defense mechanism against oxidative stress, values in
the G4 group were found to be similar to that of G1,
although that did not reach any statistical significance.
These findings suggest that CoQ10 is a neuronal pro-
tector against oxidative damage in traumatic brain
injury and that it functions by inhibiting lipid peroxi-
d a t i o n .W h e na s s e s s i n gt h ed a t ao fP O N ,a n
Table 2 Parenchymal features and neuronal morphology
distributions among groups (Continued)
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Figure 1 Histological appearances of the groups.A ,B :G 1 ;
histological appearances of normal brain parenchyma (hematoxylin
and eosin (H&E), A: × 100, B: × 400). C, D: G2; edema in brain
parenchyma, pyknotic changes (green arrow), nuclear
hyperchromasia, and cytoplasmic eosinophilia (red arrow) in
neurons are observed (H&E, C: × 100; D: × 1000, oil immersion). E, F:
G4; axonal edema and moderate reactive and degenerative changes
in neuronal structures are seen (H&E, E: × 100; F: × 400).
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lipoprotein structure, no difference was detected
among the different groups.
From the results of our histomorphological assess-
ment, it has been concluded that in rats, administration
of CoQ10 after traumatic brain injury (G4 group)
reduces vascular congestion, neuronal loss, nuclear
pyknosis, nuclear hyperchromasia, cytoplasmic, and axo-
nal edema in a statistically significant manner when
compared to the G2 and G3 groups (p <0 . 0 5 ) .M o r e -
over, by administering CoQ10, neuronal degenerative
findings were significantly less intense (p < 0.05).
5. Conclusions
The results of this study suggest that CoQ10 support
immediately after brain injury prevents lipid peroxida-
tion due to the antioxidant activity of CoQ10;C o Q 10
administration is also effective in protecting against
secondary neuronal damages after trauma. However,
the main limitation of our study is that we investigated
only the short-term effects of CoQ10 in traumatic
brain injury. We cannot conclude whether CoQ10
causes any neuroprotection as a long-term effect.
Therefore, more studies should be carried out to eval-
uate the short- and long-term effects of CoQ10 in sec-
ondary neuronal damages after trauma and to
elucidate both its exact mechanism of action and clini-
cal efficacy.
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